{
  "actions": [
    {
      "acted_at": "2001-10-09", 
      "references": [
        {
          "reference": "CR E1833-1834", 
          "type": null
        }
      ], 
      "text": "Sponsor introductory remarks on measure.", 
      "type": "action"
    }, 
    {
      "acted_at": "2001-10-09", 
      "committee": "House Committee on Energy and Commerce", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2001-10-15", 
      "in_committee": "House Committee on Energy and Commerce", 
      "references": [], 
      "subcommittee": "Health", 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr3066-107", 
  "bill_type": "hr", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }
  ], 
  "congress": "107", 
  "cosponsors": [
    {
      "district": "7", 
      "name": "Cummings, Elijah E.", 
      "sponsored_at": "2002-04-11", 
      "state": "MD", 
      "thomas_id": "00256", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Faleomavaega, Eni F.H.", 
      "sponsored_at": "2001-11-28", 
      "state": "AS", 
      "thomas_id": "00367", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "6", 
      "name": "Holden, Tim", 
      "sponsored_at": "2002-04-11", 
      "state": "PA", 
      "thomas_id": "00550", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "14", 
      "name": "Sawyer, Tom", 
      "sponsored_at": "2002-04-17", 
      "state": "OH", 
      "thomas_id": "01022", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2001-10-09", 
  "number": "3066", 
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act to establish labeling and advertising requirements for dietary supplements containing ephedrine alkaloids, to prohibit sales of such supplements to individuals under the age of 18, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Ephedrine Alkaloid Consumer Protection Act", 
  "sponsor": {
    "district": "49", 
    "name": "Davis, Susan A.", 
    "state": "CA", 
    "thomas_id": "01641", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2001-10-09", 
  "subjects": [
    "Advertising", 
    "Agriculture and food", 
    "Caffeine", 
    "Child safety", 
    "Commerce", 
    "Communication in medicine", 
    "Consumer protection", 
    "Deceptive advertising", 
    "Dietary supplements", 
    "Electronic government information", 
    "Families", 
    "Government operations and politics", 
    "Health", 
    "Health warnings", 
    "Herbs", 
    "Internet", 
    "Labeling", 
    "Medicinal plants", 
    "Pregnant women", 
    "Public lands and natural resources", 
    "Retail trade", 
    "Science, technology, communications", 
    "Telephone", 
    "Warning labels", 
    "Web sites", 
    "Women"
  ], 
  "subjects_top_term": "Agriculture and food", 
  "summary": {
    "as": "Introduced", 
    "date": "2001-10-09", 
    "text": "Ephedrine Alkaloid Consumer Protection Act - Amends the Federal Food, Drug, and Cosmetic Act to provide that if a dietary supplement contains ephedrine alkaloids, it will be misbranded if: (1) its labeling and advertising fails to contain a specified warning; or (2) the sale of the supplement is made to an individual under the age of 18, or in the case of a sale at retail, the purchaser has direct access to the supplement at the retail establishment involved, rather than the supplement being held at a portion of the establishment not intended to be accessible to customers of the establishment."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "Ephedrine Alkaloid Consumer Protection Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "To amend the Federal Food, Drug, and Cosmetic Act to establish labeling and advertising requirements for dietary supplements containing ephedrine alkaloids, to prohibit sales of such supplements to individuals under the age of 18, and for other purposes.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:49:37-05:00"
}